Literature DB >> 11450068

Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters.

H M Fernandes1, S Siddique, K Banister, I Chambers, T Wooldridge, B Gregson, A D Mendelow.   

Abstract

Sixty-two patients with a spontaneous supratentorial haemorrhage had continuous Intracranial Pressure (ICP) and Cerebral Perfusion Pressure (CPP) monitoring. In addition to the recordings of physiological data their past medical history, presenting neurological state, Computed Tomograph (CT) findings, daily Glasgow Coma Score (GCS) and outcome were noted. The mean age was 57.6 years (sd 13.3). Onset of recording, after ictus was at a mean of 32.6 hours (sd 26.0). Average length of recording was 62.0 hours (sd 39.8). Thirty-one patients had evacuation of haematoma, 6 insertion of External Ventricular Drain (EVD). Preoperative measures of ICP were significantly related to delayed neurological deterioration, death within three days and Glasgow Outcome Scale (GOS) at neurosurgical discharge. No such relationships existed with preoperative measures of CPP and neither ICP nor CPP was related to outcome at 6 months. Post-operative measures of both ICP and CPP demonstrated a significant relationship with death within three days of ictus and GOS at neurosurgical discharge. Again no relationship existed with these parameters and outcome at six months. Surgical evacuation of haematoma acted to significantly reduce ICP and improve CPP. Given that these factors seem to be related to deterioration, death and early outcome, it would seem that surgery could play a role in reducing mortality and improving outcome following Intra cerebral Haemorrhage (ICH).

Entities:  

Mesh:

Year:  2000        PMID: 11450068     DOI: 10.1007/978-3-7091-6346-7_96

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  24 in total

Review 1.  Steps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhage.

Authors:  Daniel Agustin Godoy; Gustavo Rene Piñero; Patricia Koller; Luca Masotti; Mario Di Napoli
Journal:  World J Crit Care Med       Date:  2015-08-04

2.  Decompressive craniectomy for intracerebral haematoma: the influence of additional haematoma evacuation.

Authors:  Alexis Hadjiathanasiou; Patrick Schuss; Inja Ilic; Valeri Borger; Hartmut Vatter; Erdem Güresir
Journal:  Neurosurg Rev       Date:  2017-09-27       Impact factor: 3.042

Review 3.  The use of targeted temperature management for elevated intracranial pressure.

Authors:  Jesse J Corry
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

4.  Emergency Neurological Life Support: Intracerebral Hemorrhage.

Authors:  J Claude Hemphill; Arthur Lam
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

Review 5.  Emergency Neurological Life Support: Intracerebral Hemorrhage.

Authors:  Edward C Jauch; Jose A Pineda; J Claude Hemphill
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

Review 6.  Therapeutic strategies in acute intracerebral hemorrhage.

Authors:  H Bart Brouwers; Joshua N Goldstein
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

7.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

8.  Current treatment options for intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

Review 9.  Emergency neurological life support: intracerebral hemorrhage.

Authors:  Charles M Andrews; Edward C Jauch; J Claude Hemphill; Wade S Smith; Scott D Weingart
Journal:  Neurocrit Care       Date:  2012-09       Impact factor: 3.210

Review 10.  Clinical review: Critical care management of spontaneous intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.